Author: Parra Jorge
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.31, Iss.8, 2011-08, pp. : 527-542
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Carter Natalie J. Keating Gillian M.
Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. :
Valaciclovir:development, clinical utility and potential
By Patel R.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 2, 1997-02 ,pp. :
Remifentanil Update: Clinical Science and Utility
By Richard Beers Enrico Camporesi
CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. :
Clinical Utility of Biomarkers in Premature Atherosclerosis
Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. :